First, individual patient data (IPD) were not available, which restricted our ability to perform subgroup analyses based on detailed patient-level variables such as ethnicity, cancer stage, or medication adherence
Cost, access & the right fit Pricing, insurance coverage, and supply differ between the two and change frequently
They tend to have fewer gastrointestinal side effects but may be less effective in terms of total weight loss
What the evidence does not show: No randomized trial has demonstrated meaningful weight loss, cardiovascular benefit, or metabolic benefit from weekly tirzepatide doses below 2.5 mg
Intellectual disability (Chapter 5): Assign the severity code (F70F73, F78, F79)
The precision of this type of treatment means patients dont have to worry about unintended trauma to surrounding skin tissue